Sign In
Buy CIZN
$10.74
+0.0900 (+0.85%)
At Close: Jul 31, 2026
Citizens Financial Rises Nearly 42% in a Year: Is It Worth Buying Now?
01:10pm, Tuesday, 31'st Mar 2026
Can CFG stock keep climbing after a 41.5% surge, or do valuation, rising costs and loan risks limit further upside? Let us discuss.
Citizens, Inc. to Participate at Emerging Growth Virtual Conference on April 2, 2026
09:20am, Tuesday, 31'st Mar 2026
Austin, Texas--(Newsfile Corp. - March 31, 2026) - Citizens, Inc. (NYSE: CIA), a leading diversified financial services company specializing in life, living benefits, and final expense insurance, toda
Citizens Initiates Coverage of Live Nation at Outperform With $190 Target
09:53am, Monday, 30'th Mar 2026
Live Nation Entertainment (NYSE:LYV) has delivered a 13.48% gain over the past year.
Citizens Financial Services Has A Structural Advantage As Interest Rates Fall
07:45am, Wednesday, 25'th Mar 2026
Citizens Financial Services is rated a 'buy' due to its compelling valuation and improving fundamentals. CZFS benefits from a declining interest rate environment, with net interest margin and net inte
Citizens Deepens San Francisco Commitment through Community and Economic Investments
11:00am, Tuesday, 17'th Mar 2026
SAN FRANCISCO--(BUSINESS WIRE)--Citizens today announced a series of coordinated community and economic investments that underscore its long-term commitment to San Francisco as a place to do business,
Citizens Financial's Revenues Rise in 2025: Will Growth Continue?
02:20pm, Monday, 16'th Mar 2026
Citizens Financial Group CFG delivered steady revenue growth in 2025, supported by higher net interest income (NII) and non-interest income. The company reported total revenues of $8.25 billion, which
Citizens (CIA) Q4 Earnings and Revenues Surpass Estimates
08:31pm, Thursday, 12'th Mar 2026
Citizens (CIA) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of $0.08 per share. This compares to earnings of $0.07 per share a year ago.
Citizens, Inc. Reports Full Year and Fourth Quarter 2025 Financial Results
04:05pm, Thursday, 12'th Mar 2026
Highest ever full year total revenues: $255.6 million in 2025, up from $245.0 million in 2024.Adjusted total revenues of $255.5 million in 2025, from $247.6 million in 2024. Record quarter for total r
Citizens Financial Group Announces First Quarter 2026 Earnings Conference Call Details
04:05pm, Tuesday, 10'th Mar 2026
PROVIDENCE, R.I.--(BUSINESS WIRE)--As previously announced, Citizens Financial Group, Inc. (NYSE: CFG) will report its first quarter 2026 earnings on April 16, 2026. The news release and supplemental
Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference
04:05pm, Wednesday, 04'th Mar 2026
BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced that management will participate in a fireside chat at The Citizens Life Sciences Conference on Wednesday, March
ProQR Announces Webcast of Presentation at the 2026 Citizens Life Sciences Conference
04:30pm, Tuesday, 03'rd Mar 2026
LEIDEN, Netherlands & CAMBRIDGE, Mass., March 03, 2026 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of First Citizens BancShares, Inc. - FCNCA
03:32pm, Tuesday, 03'rd Mar 2026
NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of First Citizens BancShares, Inc. (“First Citizens” or the “Company”) (NASDAQ: FCNCA)
Anavex Life Sciences to Present at the Citizens Life Sciences Conference
07:30am, Tuesday, 03'rd Mar 2026
NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative
Enanta Pharmaceuticals to Present at The Citizens Life Sciences Conference
07:00am, Tuesday, 03'rd Mar 2026
WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological
Avanos Medical, Inc. to Present at the 2026 Citizens Life Sciences Conference
05:28pm, Monday, 02'nd Mar 2026
ALPHARETTA, Ga., March 2, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Dave Pacitti, chief executive officer, and Scott Galovan, senior vice president and chief financ
